Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Shares Bought by KBC Group NV
KBC Group NV increased its position in Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) by 54.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the ...
JMP Securities Reiterates “Market Outperform” Rating for Protagonist Therapeutics (NASDAQ:PTGX)
JMP Securities reiterated their market outperform rating on shares of Protagonist Therapeutics (NASDAQ:PTGX – Free Report) in a research report report published on Friday,Benzinga reports. They ...
American Association of Individual Investors5h
Which Is a Better Investment, Protagonist Therapeutics, Inc. or Twist Bioscience Corporation Stock?
Learn more about whether Protagonist Therapeutics, Inc. or Twist Bioscience Corporation is a better investment based on ...
American Association of Individual Investors4h
Which Is a Better Investment, Protagonist Therapeutics, Inc. or Roivant Sciences Ltd. Stock?
Learn more about whether Protagonist Therapeutics, Inc. or Roivant Sciences Ltd. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Investor's Business Daily on MSN7h
Stocks Generating Improved Relative Strength: Protagonist Therapeutics
Protagonist Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating ...